{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:52:06Z","timestamp":1770501126457,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T00:00:00Z","timestamp":1139961600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement. Amphotericin B is more frequently used as initial therapy if the patient's deterioration is rapid.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 31-year-old Korean male with coccidioidomycosis presented to the hospital with miliary infiltrates on chest X-ray (CXR) and skin rash on the face and trunk. Initially, the patient did not respond to amphotericin B deoxycholate therapy. However, following caspofungin and fluconazole combination therapy, the patient showed favourable radiological, serological, and clinical response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This appears to be the first case of diffuse coccidioidal pneumonia with skin involvement in an immunocompetent patient who was treated successfully with caspofungin and fluconazole. Combination therapy with caspofungin and fluconazole may, therefore, be an alternative treatment for diffuse coccidioidal pneumonia that does not respond to amphotericin B deoxycholate therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-6-26","type":"journal-article","created":{"date-parts":[[2006,2,17]],"date-time":"2006-02-17T07:45:46Z","timestamp":1140162346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole"],"prefix":"10.1186","volume":"6","author":[{"given":"Dae Won","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang Wook","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ja Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je Hyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,15]]},"reference":[{"issue":"16","key":"290_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJM199504203321607","volume":"332","author":"DA Stevens","year":"1995","unstructured":"Stevens DA: Coccidioidomycosis. N Engl J Med. 1995, 332 (16): 1077-1082. 10.1056\/NEJM199504203321607.","journal-title":"N Engl J Med"},{"issue":"2","key":"290_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1378\/chest.117.2.404","volume":"117","author":"EL Arsura","year":"2000","unstructured":"Arsura EL, Kilgore WB: Miliary coccidioidomycosis in the immunocompetent. Chest. 2000, 117 (2): 404-409. 10.1378\/chest.117.2.404.","journal-title":"Chest"},{"issue":"1","key":"290_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0891-5520(02)00040-5","volume":"17","author":"TM Chiller","year":"2003","unstructured":"Chiller TM, Galgiani JN, Stevens DA: Coccidioidomycosis. Infect Dis Clin North Am. 2003, 17 (1): 41-57, viii. 10.1016\/S0891-5520(02)00040-5.","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"290_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/00001432-200112000-00005","volume":"14","author":"SC Deresinski","year":"2001","unstructured":"Deresinski SC: Coccidioidomycosis: efficacy of new agents and future prospects. Curr Opin Infect Dis. 2001, 14 (6): 693-696.","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"290_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1086\/313747","volume":"30","author":"JN Galgiani","year":"2000","unstructured":"Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL: Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis. 2000, 30 (4): 658-661. 10.1086\/313747.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"290_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1086\/496991","volume":"41","author":"JN Galgiani","year":"2005","unstructured":"Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL: Coccidioidomycosis. Clin Infect Dis. 2005, 41 (9): 1217-1223. 10.1086\/496991.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"290_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1086\/430303","volume":"40","author":"GM Anstead","year":"2005","unstructured":"Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR: Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis. 2005, 40 (12): 1770-1776. 10.1086\/430303.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"290_CR8","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1086\/424019","volume":"39","author":"RM Prabhu","year":"2004","unstructured":"Prabhu RM, Bonnell M, Currier BL, Orenstein R: Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004, 39 (7): e74-7. 10.1086\/424019.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"290_CR9","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.41.7.1558","volume":"41","author":"JE Lutz","year":"1997","unstructured":"Lutz JE, Clemons KV, Aristizabal BH, Stevens DA: Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother. 1997, 41 (7): 1558-1561.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"290_CR10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1086\/375080","volume":"36","author":"SC Deresinski","year":"2003","unstructured":"Deresinski SC, Stevens DA: Caspofungin. Clin Infect Dis. 2003, 36 (11): 1445-1457. 10.1086\/375080.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"290_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jac\/dkg117","volume":"51","author":"V Letscher-Bru","year":"2003","unstructured":"Letscher-Bru V, Herbrecht R: Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother. 2003, 51 (3): 513-521. 10.1093\/jac\/dkg117.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"290_CR12","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1128\/AAC.45.6.1854-1859.2001","volume":"45","author":"GM Gonzalez","year":"2001","unstructured":"Gonzalez GM, Tijerina R, Najvar LK, Bocanegra R, Luther M, Rinaldi MG, Graybill JR: Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother. 2001, 45 (6): 1854-1859. 10.1128\/AAC.45.6.1854-1859.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"290_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1086\/423811","volume":"39","author":"S Antony","year":"2004","unstructured":"Antony S: Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis. 2004, 39 (6): 879-880. 10.1086\/423811.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"290_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/jac\/dkh306","volume":"54","author":"G Hsue","year":"2004","unstructured":"Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR: Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother. 2004, 54 (1): 292-294. 10.1093\/jac\/dkh306.","journal-title":"J Antimicrob Chemother"},{"key":"290_CR15","volume-title":"Drug interactions of caspofungin(C) with conventional agents against pathogens of endemic mycoses [abstract M-863]: San Diego.","author":"DA Stevens","year":"2002","unstructured":"Stevens DA: Drug interactions of caspofungin(C) with conventional agents against pathogens of endemic mycoses [abstract M-863]: San Diego.2002, American Society for Microbiology,"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-6-26\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-6-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:33:06Z","timestamp":1630449186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-6-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,15]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-6-26","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,15]]},"assertion":[{"value":"4 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"26"}}